Immunology, Virology, Antibody, Immune system and Immunity are her primary areas of study. Her work focuses on many connections between Immunology and other disciplines, such as Natural killer cell, that overlap with her field of interest in KIR3DL1. Her Virology study combines topics in areas such as Epitope, Antigen and Cytotoxic T cell.
Her biological study spans a wide range of topics, including Receptor and Adoptive cell transfer. Her studies in Immune system integrate themes in fields like Cellular differentiation, Viral load and Monocyte. Her Immunity research is multidisciplinary, incorporating elements of Infectious disease, Inflammasome, Pneumonia, Viremia and Immunogenicity.
Her primary areas of investigation include Immunology, Antibody, Virology, Immune system and Immunity. Her study looks at the intersection of Immunology and topics like Receptor with Human leukocyte antigen. Galit Alter has included themes like Antigen and Vaccination in her Antibody study.
Galit Alter has researched Virology in several fields, including Epitope and Monoclonal antibody. Her work investigates the relationship between Immune system and topics such as Serology that intersect with problems in Cohort. The study incorporates disciplines such as Disease and Antibody titer in addition to Immunity.
The scientist’s investigation covers issues in Antibody, Immunology, Immune system, Virology and Immunity. Her Antibody study combines topics in areas such as Severe acute respiratory syndrome coronavirus 2, Antigen and Vaccination. Many of her research projects under Immunology are closely connected to Mycobacterium tuberculosis with Mycobacterium tuberculosis, tying the diverse disciplines of science together.
Her Immune system study combines topics from a wide range of disciplines, such as HIV vaccine, Germinal center, B cell and Coronavirus. Her biological study spans a wide range of topics, including Immunization and Monoclonal antibody. The concepts of her Immunity study are interwoven with issues in Cellular immunity and Antibody titer.
Galit Alter mainly investigates Antibody, Immunology, Immune system, Virology and Immunity. The various areas that Galit Alter examines in her Antibody study include Internal medicine, Pandemic and Severe acute respiratory syndrome coronavirus 2. Specifically, her work in Immunology is concerned with the study of Humoral immunity.
Her studies in Humoral immunity integrate themes in fields like Innate immune system, Neutralization and Disease. Her research integrates issues of Germinal center and Coronavirus in her study of Immune system. Her Virology study integrates concerns from other disciplines, such as Epitope and Immunogenicity.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
CD107a as a functional marker for the identification of natural killer cell activity
Galit Alter;Jessica M. Malenfant;Marcus Altfeld.
Journal of Immunological Methods (2004)
DNA vaccine protection against SARS-CoV-2 in rhesus macaques.
Jingyou Yu;Lisa H. Tostanoski;Lauren Peter;Noe B. Mercado.
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.
Bina Choi;Manish C. Choudhary;James Regan;Jeffrey A. Sparks.
The New England Journal of Medicine (2020)
SARS-CoV-2 infection protects against rechallenge in rhesus macaques.
Abishek Chandrashekar;Jinyan Liu;Amanda J. Martinot;Amanda J. Martinot;Katherine McMahan.
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.
Noe B. Mercado;Roland Zahn;Frank Wegmann;Carolin Loos;Carolin Loos.
Correlates of protection against SARS-CoV-2 in rhesus macaques.
Katherine McMahan;Jingyou Yu;Noe B. Mercado;Carolin Loos;Carolin Loos.
Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1
Angela Meier;J Judy Chang;Ellen S Chan;Richard B Pollard.
Nature Medicine (2009)
Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes
Galit Alter;Maureen P. Martin;Nickolas Teigen;William H Carr.
Journal of Experimental Medicine (2007)
SARS-CoV-2 viral load is associated with increased disease severity and mortality.
Jesse Fajnzylber;James Regan;Kendyll Coxen;Heather Corry.
Nature Communications (2020)
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients.
Anita S. Iyer;Forrest K. Jones;Ariana Nodoushani;Meagan Kelly.
Science immunology (2020)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: